Incintas Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Moccasin Dr, Atglen, Pennsylvania, 193...Website
www.incintas.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Incintas Therapeutics
Incintas Therapeutics, Inc. is focused on improving pregnancy outcomes in reproductive medicine, particularly in the field of in vitro fertilization (IVF). The company has developed a proprietary time-released liquid therapeutic that modulates and prolongs uterine receptivity by delivering the ideal concentration of progesterone directly within the uterus. This innovative approach aims to overcome the 33% fertility plateau associated with failed embryonic implantation, thereby increasing the likelihood of successful pregnancies for couples undergoing IVF or intrauterine insemination (IUI). Incintas is committed to helping fertility-challenged families by providing a more effective and less costly solution for assisted reproduction.Explore more
Incintas Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Incintas Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Incintas Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Incintas Therapeutics has new funding data
Incintas Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Incintas Therapeutics
Click to see if Incintas Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Incintas Therapeutics launches new products
Check if Incintas Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Incintas Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Incintas Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Incintas Therapeutics
Compare insights from companies similar to Incintas Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Incintas Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Incintas Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Incintas Therapeutics.
Incintas Therapeutics Tech Stack
A closer look at the technologies used by Incintas Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Incintas Therapeutics
Sign Up For FreeTo access detailed company insights
Incintas Therapeutics, Inc. is focused on improving pregnancy outcomes in reproductive medicine, particularly in the field of in vitro fertilization (IVF). The company has developed a proprietary time-released liquid therapeutic that modulates and prolongs uterine receptivity by delivering the ideal concentration of progesterone directly within the... Read More
